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Abstract
ESRP1 regulates alternative splicing, producing multiple transcripts from its target genes in
epithelial tissues. It is upregulated during mesenchymal to epithelial transition associated
with reprogramming of fibroblasts to iPS cells and has been linked to pluripotency. Mouse
fetal germ cells are the founders of the adult gonadal lineages and we found that Esrp1
mRNA was expressed in both male and female germ cells but not in gonadal somatic cells
at various stages of gonadal development (E12.5-E15.5). In the postnatal testis, Esrp1
mRNA was highly expressed in isolated cell preparations enriched for spermatogonia but
expressed at lower levels in those enriched for pachytene spermatocytes and round sper-
matids. Co-labelling experiments with PLZF and c-KIT showed that ESRP1 was localized to
nuclei of both Type A and B spermatogonia in a speckled pattern, but was not detected in
SOX9+ somatic Sertoli cells. No co-localization with the nuclear speckle marker, SC35,
which has been associated with post-transcriptional splicing, was observed, suggesting that
ESRP1 may be associated with co-transcriptional splicing or have other functions. RNA
interference mediated knockdown of Esrp1 expression in the seminoma-derived Tcam-2
cell line demonstrated that ESRP1 regulates alternative splicing of mRNAs in a non-epithe-
lial cell germ cell tumour cell line.
Introduction
Germ cells exhibit unique profiles of gene expression that distinguish them from somatic
cells (reviewed in [1]) and utilise specific transcriptional regulators, which produce transcripts
that differ from those observed in other tissues [2]. Transcript diversity also derives from an
extensive array of post-transcriptional regulation that is present in differentiating germ cells
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including extensive alternative splicing of pre-mRNA molecules that amplifies the number of
proteins produced from a finite number of genes [3–8]. Genome-wide analyses of alternative
splicing of transcripts in the gonads of Drosophila and mice, have demonstrated the existence
of many germ-cell specific protein isoforms [8, 9] and a high frequency of alternate splicing
events in the testis [10, 11]. The Drosophila study also identified RNA splicing factors that are
highly enriched in pre-meiotic cells [9]. While the core elements of the RNA splicing mecha-
nism are ubiquitously expressed and regulate mRNA splicing in all cells, splicing profiles differ
between cells [12], suggesting that tissue specific regulators generate cell specific splicing
events. In pursuit of this hypothesis, Warzecha et al. [13] conducted a genome wide screen to
identify new factors that could uniquely promote splicing in epithelial cells. Among various
factors, two protein paralogues were found to cause epithelial specific splicing patterns. Previ-
ously, these proteins were known as RNA binding motif proteins 35A and 35B (RBM35A and
RBM35B). Expression of both genes is highly cell type specific, but up-regulation of both genes
was generally observed in epithelial cell types. These proteins were thus renamed epithelial
splicing regulatory proteins 1 and 2 (ESRP1 and ESRP2) [13].
Up-regulation of ESRP1 and ESRP2 expression coincides with the earliest changes in global
gene expression associated with the mesenchymal to epithelial transition and induction of
pluripotency during iPS cell generation [14, 15]. Moreover, a recent study of alternative splic-
ing events, which occur during reprogramming of mouse embryonic fibroblasts to iPS cells,
identified enrichment of ESRP1 binding sites upstream of alternatively spliced exons. Subse-
quent knockdown of ESRP1/2 followed by RNA-Seq analysis demonstrated that ESRP1/2
dependent splicing events occur during the induction of pluripotency [16].
Mouse spermatogonial stem cells, in addition to their capacity to repopulate germ cell-
depleted seminiferous tubules [17], display pluripotent characteristics when isolated and cultured
under the same conditions as embryonic stem cells [18–21] including expression of pluripotency
markers (e.g. Oct4, Nanog, Rex-1), differentiation along mesodermal and neuroectodermal line-
ages, formation of teratomas when injected into SCID mice and generation of chimeras when
injected into host blastocysts [18–21]. Similarly, pluripotent cells have been isolated from human
testes [22, 23] but appear to be less competent or not as efficient as ES cells in forming chimeras
and teratomas (reviewed in [24]). Comparison of rodent adult germline stem cells with ES cells
by expression profiling demonstrated that they are almost identical, express the same level of
pluripotency genes and respond similarly in differentiation assays [25].
Given the high level of alternate splicing during spermatogenesis and the association of
ESRP1 with pluripotency, we were interested in examining the expression of ESRP1 during
the development of male and female germ cells. Germ cells in the mouse are derived from a
small number of cells present in the epiblast at E6.25 (embryonic day 6.25 after fertilization)
that receive a BMP signal from extraembryonic ectoderm. After limited proliferation, these
cells migrate, by both passive and actively directed transport and are found by E11.5 in the
genital ridges, which are the gonadal precursors. By day E13.5 male fetal germ cells down regu-
late pre-meiotic genes, enter mitotic arrest and are termed gonocytes, whereas female embry-
onic germ cells differentiate into oogonia, which enter meiosis and arrest in prophase I. By
birth, the majority of oogonia have either degenerated, or developed into primordial follicles,
that remain in meiotic arrest unless selected for maturation during the adult female reproduc-
tive cycle. By contrast, gonocytes remain mitotically arrested until around post-natal day 3 in
males, before re-entering the cell cycle and forming spermatogenic stem cells within the semi-
niferous tubules. The spermatogenic stem cells subsequently produce spermatogonia that will
differentiate into spermatocytes. Each spermatocyte undergoes two meiotic divisions to pro-
duce four haploid round spermatids that undergo a morphological change to produce elongat-
ing spermatids, and eventually, mature spermatozoa (reviewed in [26]).
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In this study we identify that Esrp1 is transcribed in fetal germ cells and in perinatal gono-
cytes/spermatogonia and shows enriched expression in adult spermatogonia. In addition, we
show that ESRP1 protein is most highly expressed in nuclei of pre-meiotic germ cells in adult




All animal procedures were approved by the Animal Ethics Committees of the University of
Melbourne, the Murdoch Children’s Research Institute and the University of Newcastle. Mice
(FVB, C57Bl6/J, CD1, and OG2) were maintained under standard housing conditions with ad
libitum access to rodent chow and water and under a 12 hour dark, 12 hour light cycle. Wild-
type mouse strains were obtained from ARC (Murdoch WA, Australia) and maintained as
inbred colonies. OG2 mice (Jackson Lab Stock 004654), which express enhanced green fluo-
rescent protein under the control of the Pou5f1 promoter and distal enhancer [27] were main-
tained as homozygous transgenic strain on a C57Bl6/J background [28].
Isolation of gonadal germ and somatic cells
Fetal gonadal germ and somatic cells were isolated as previously described [28, 29]. Briefly,
fetal (E12.5 –E15.5) gonads were dissected and dissociated cells were fluorescent-activated cell
sorting (FACS) to isolate GFP+ germ cells and GFP- somatic cells. The identity of each isolated
cell type was confirmed by immunofluorescence for specific germ cell (OCT4, MVH) and
somatic cell (SOX9) markers [28].
Testes from 1 day (for isolation of gonocytes/spermatogonia), 8–10 day (spermatogonia)
and 8 week (pachytene spermatocytes and round spermatids) old wild-type mice were dissoci-
ated using a combination of 0.5 mg/ml collagenase and 0.25% trypsin and separated on 2–4%
continuous bovine serum albumin (BSA) gradient as described previously [30, 31]. RT-ddPCR
was used to confirm the identities of the separated cell populations as described (Ccnd1 and
Ngn3 were used to show enrichment of gonocytes/spermatogonia) [32], Dnah8 showed enrich-
ment of pachytene spermatocytes and Tob1 showed enrichment of round spermatids [29]. We
obtained three independent biological replicates of enriched gonocytes, spermatogonia and
pachytene spermatocytes but only two replicates of round spermatids.
Cell culture and RNA interference
The TCam-2 cell line, which derives from a primary testicular seminoma [33] and exhibits
characteristics of fetal germ cells [34] was cultured in RPMI 1640 medium (Thermo Fisher Sci-
entific, Scoresby VIC, Australia) supplemented with 10% fetal calf serum (Life Technologies,
Mulgrave VIC, Australia) and penicillin/streptomycin diluted 1:200 (Thermo Fisher Scientific)
at 37˚C in 5% CO2 in a humidified incubator.
To conduct ESRP1 knockdown experiments, two Silencer1 siRNAs and a negative control
were obtained from Ambion/ThermoFisher (Table 1). On the day prior to transfection,
TCam-2 cells (~0.6 ×106 cells/well) were seeded in RPMI medium in the absence of antibiotic
in 6 well culture plates (3 per control and 3 per siRNA pair) (Nunclon™ Delta, ThermoFisher).
The siRNA (25 ρmole) and 3% Lipofectamine RNAiMAX (Invitrogen/Life Technologies)
diluted in Opti-MEM1 medium (Invitrogen/Life Technologies), as specified in the manufac-
turer’s instructions, were added to cells in each culture well. After 48 or 72 h of culture the cells
were harvested and extracted for Western blotting.
Expression of Esrp1 in germ cells
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Cycloheximide chase assay
To investigate the stability of ESRP1 protein, TCam-2 cells were subjected to a cycloheximide
chase assay. The transfection medium was replaced with RPMI medium containing 50 μg/ml
cycloheximide (CHX) added into each well. At various time-points after addition of the cyclo-
heximide (t = 24, 48, 72 hours), cells were harvested, centrifuged and lysed in RIPA buffer con-
taining protease inhibitors for western blotting analysis.
Western blot
Protein concentrations of cell lysates were determined using a bicinchoninic acid protein
assay kit (BCA kit; ThermoFisher Scientific) and 10 μg of protein from each sample were elec-
trophoresed on a 10% SDS PAGE gel and transferred onto an Immobilon-P PVDF membrane
(Millipore, Australia). After blocking (5% milk powder and 0.05% Tween-20 in PBS) the mem-
branes were incubated overnight at 4˚C with anti-ESRP1 (HPA023719; Sigma; 1:250) and
anti-β-actin (A5441, Sigma, 1:5000) antibodies, diluted in 5% BSA in PBS/Tween-20. After
washes in PBS/Tween-20 the membranes were incubated for 1 h at room temperature with the
appropriate HRP-conjugated secondary antibodies (Invitrogen) diluted in PBS/BSA/Tween-
20. Signals were visualized using Clarity TM Western ECL substrates (BioRad) according to
the manufacturer’s recommended protocol and imaged with a ChemiDocTM MP system
(Bio-Rad).
RNA extraction, cDNA synthesis, RT-PCR and droplet digital PCR
(ddPCR)
RNA was extracted from gonadal cell populations, gonadal tissues and cultured TCam-2 cells
using RNeasy mini kits (Qiagen, Australia) with on-column DNA digestion, as per manufac-
turer’s instructions. The quality and quantity of total RNAwas assayed using an Agilent 2200
Tape Station (Agilent Technologies, Germany). For each sample, 100 ng total RNA was
reverse transcribed using iScript™ Advanced cDNA Synthesis Kit (Bio-Rad, USA) according
to manufacturer’s instructions. Expression analyses were performed by droplet digital PCR
(ddPCR) as described previously [29]; see Table 2) on at least three separate cell or tissue isola-
tions normalized to house-keeping genes (Mapk1, Canx or Ppia) and data were expressed as
mean ± standard error of the mean (S.E.M.).
To examine splicing events in cultured TCam-2 cells, RNA was extracted from control and
siRNA transfected cells as described above and analyzed by standard RT-PCR and gel electro-
phoresis to detect splicing of CTNND1 and DOCK7. As DOCK7 splice variants show alterna-
tive splicing of exon 23 (93 nt) we designed primers to exon 22 (5’-GCTAGATCTGCGGTG
AGACC-3’) and exon 24 (5’-TCTGTGTGCGAAGACATACG-3’) to detect splice variants
and primers to constant exons 2 (5’-TAGTGGTTCTCCCCAACTGC-3’) and 4 (5’-GGAT
CCATTTCACTTTCTTCAGG-3’) to detect the all DOCK7 transcripts. Similarly, to detect
Table 1. siRNA target sequences.
siRNA ID Silencer1Select 1. Sense Sequence (5’-3’)
2. Antisense Sequence (5’-3’)







Negative Control #4390843 #AS023T9Q
https://doi.org/10.1371/journal.pone.0190925.t001
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alternate splicing of CTNND1 at exons 2 and 3, we designed primers in exon 1 (5’-TGTCT
TTCTCAGCACCTTGG-3’) and exon 4 (5’-GTCTTTCAAGGTCAGCATCG-3’) to detect
splice variants and primers to the constant exon 5 (5’-CAGATGATGGGACCACTCG-3’) and
exon 6 (5’-TCTAGCCCATAAGGCTCTGG-3’) to detect all CTNND1 transcripts.
Immunofluorescence
Immunofluorescence, incorporating antigen retrieval with acidic citrate buffer at 100˚C, was
carried out on paraffin sections of formalin-fixed ovaries and testes from 12-week old mice as
described previously [29]. Antibodies used included two rabbit polyclonal anti-human ESRP1
(HPA023719 and HPA023720; Sigma Aldrich) diluted 1:100 and 1:50 for testis and ovary spec-
imens respectively, a goat polyclonal anti-mouse c-KIT (AF1356, R&D system) diluted 1:250, a
goat polyclonal anti-human PLZF (AF2944, R &D system) diluted 1:500, a sheep anti-Sox9
antibody (provided by Dr Dagmar Wilhelm) diluted 1:100 and a mouse monoclonal antibody
to the nuclear speckle/spliceosome marker, SC35 (ab11826, AbCam) diluted 1:250. Negative
controls included sections incubated with non-immune rabbit serum (NIS). Reactivity was
visualized using appropriate secondary antibodies conjugated to Alexafluor-488 or Alexafluor-
596 (Invitrogen, Australia), diluted 1:500 and imaged using a Zeiss LSM800 confocal micro-
scope (Carl Zeiss, Melbourne, VIC, Australia).
For immunofluorescence of cultured TCam-2 cells, the cells were grown on 13 mm round
plastic coverslips (Thermanox™) in six-well culture plates as described above. Following siRNA
transfection, cells were cultured in RPMI medium for various periods (24, 48, 72 hours) before
being fixed in 4% paraformaldehyde in PBS for 20 min, and permeabilized for 20 min in 0.2%
TritonX-100 in PBS. After blocking with 10% FCS in PBS for 30 min, cells were incubated
overnight at 4˚C with anti-ESRP1 primary antibody (HPA023719; Sigma) diluted 1:50 in
blocking buffer. Antibody binding was detected by incubating with 1:500 AlexaFluor
488-conjugated donkey anti-rabbit IgG (Invitrogen A-21052) for 1h. Cells were counter-
stained with 1 μg/ml Hoechst dye and 1 μg/ml Phalloidin-TRITC (Sigma) for 1h. Matching
Table 2. Digital PCR primer and probe sequences.













Ppia Primer sequences not available, FAM
RefSeq NM_008907.1, assay location 232, exon boundary 3–4
112 TF/Mm02342429_g1
Ngn3 Primer sequences not available, FAM
RefSeq NM_009719.6, assay location 493, exon boundary 2–2
73 TF/Mm00437606_s1
Ccnd1 Primer sequences not available, FAM
RefSeq NM_007631.2, assay location 957, exon boundary 4–5
145 TF/Mm00432360_m1
Dnah8 Primer sequences not available, FAM
RefSeq NM_013811.3, assay location 2723, exon boundary not available
68 TF/Mm01299527_m1
Sequences of the forward (Fw), reverse (Rev) primers, and internal probe (P) sequences or the catalogue number of proprietary assays, with corresponding product
lengths, used for digital RT-PCR analyses. Abbreviations: NA, not applicable; TF = ThermoFisher.
https://doi.org/10.1371/journal.pone.0190925.t002
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plastic coverslips for each treatment were mounted onto 50 mm square glass coverslips and
visualized using confocal microscopy as described above.
Statistical analyses
For analyses of the ddPCR data, application of a Shapiro-Wilks normality test indicated the
data fitted a Gaussian distribution. Therefore, where at least three biological replicates were
available, a one-way analysis of variance with a Tukey’s post-hoc analysis and α = 0.05 was
employed to determine significant differences among groups. All statistical analyses and gen-
eration of graphs were performed using GraphPad Prism (La Jolla CA, USA).
Results
Esrp1 is expressed in fetal germ but not somatic cells
To examine Esrp1 expression specifically in fetal germ and somatic cells of murine gonads,
we took advantage of the Pou5f1-GFP (Oct4-GFP) transgenic mouse line to isolate male and
female gonadal (GFP+) and somatic (GFP-) cells at various stages of development by FACS
[28]. Using ddPCR we found that Esrp1 is highly expressed in female and male germ cells but
not somatic cells from E12.5 to E15.5 (Fig 1). These data are consistent with published micro-
array data showing detectable expression of Esrp1 in only male and female germ cells from
E11.5 –E14.5 [35]. To examine if ESRP1 protein could be detected in fetal gonads, immuno-
fluorescence experiments were conducted on mouse E12.5-E14.5 male and female gonadal
sections. However, little or no specific reactivity could be detected in somatic or germ cells
and if ESRP1 protein is produced in fetal germ cells it is below the level of detection via
immunofluorescence.
Fig 1. Esrp1 is expressed in developing male and female germ cells but not somatic cells. Histograms show Esrp1RNA expression, measured by RT-ddPCR, in
FACS sorted (A) germ (GC) and (B) somatic (SC) cells, isolated from E12.5-E15.5 mouse embryos expressing an Oct4 (Pou5f1)-GFP transgene. Gene expression is
expressed as copies/μl and normalised against Mapk1 expression in germ cells and against Canx expression in somatic cells. Data are presented as mean ± S.E.M of
three independent samples at each age. Transcripts for Esrp1were detected in male and female germ cells but not in sorted somatic cells. No significant differences
in expression were detected in Esrp1 expression with age in male or female germ cells (n = 3 for each group; One-way ANOVA, p>0.05). Abbreviations: GC, germ
cells; SC, somatic cells.
https://doi.org/10.1371/journal.pone.0190925.g001
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Esrp1 is upregulated in adult spermatogonia
To examine the expression of Esrp1 during postnatal male gametogenesis, we utilized a BSA
gradient to separately enrich gonocytes/spermatogonia (at P1), spermatogonia (at P8-10),
pachytene spermatocytes and round spermatids (at 8 weeks) as described previously [30–32].
Previous studies have demonstrated that this method can be used to isolate gonocyte- and
spermatogoinal-enriched popluations, expressing specific marker (Pou5f1, Nanog, Ngn3, Plzf)
profiles [32]. Using RT-ddPCR we confirmed (S1 Fig) that each population was specifically
enriched for gonocytes (Ccnd1), spermatogonia (Ngn3) and pachytene spermatocytes (Dnah8).
In addition, we have recently shown, using the same RNA samples as used in this study, that
the round spermatid sample uniquely expressed Tob1 [29]. The RT-ddPCR analysis indicated
that Esrp1was most strongly expressed in cell populations enriched for spermatogonia. Greatly
reduced expression was detected in pachytene spermatocytes and round spermatids (Fig 2).
To confirm ESRP1 expression in adult spermatogonia, we used immunofluorescence with a
specific antibody for ESRP1 (Fig 3). Consistent with the ddPCR data, strong nuclear immu-
nostaining for ESRP1 was detected in spermatogonia that reside close to the basal lamina of
the seminiferous tubules (arrows, Fig 3A, 3D and 3G), with expression also observed in differ-
entiating spermatocytes and spermatids. The presence of immunostaining in these cells sug-
gests that the greatly lower levels of mRNA (mean ± SEM; 852 ± 125 copies/μl; see Fig 2) are
still sufficient to allow for translation of the protein. This level of expression is more than an
order of magnitude higher than that of Ngn3 expression in spermatogonia (S1 Fig), indicating
that these lower levels of mRNA expression can still result in readily detectable protein levels.
The lack of staining with non-immune serum (Fig 3C) combined with western blot and immu-
nofluorescence analyses of ESRP1-siRNA transfected TCam-2 cells (S2 Fig) indicate that the
antibody (HPA023719) is specific. Moreover, similar patterns of reactivity were detected with
Fig 2. Esrp1 is highly expressed in spermatogonia in the adult testis. RT-ddPCR of isolated germ cells from
postnatal mouse testes show that Esrp1 is highly expressed in spermatogonia (S), weakly expressed in gonocytes/
spermatogonia (G) and barely detectable in pachytene spermatocytes (PS) and round spermatids (RS). Expression data
are expressed as copies/μl, normalised against Cyclophilin A expression, and as mean ± S.E.M of three independent
samples (except for Round Spermatids n = 2). Individual data are shown as black circles, mean as a red line and the
error bars in black. Asterisks indicate significance differences by ANOVA and Tukey’s post-hoc analysis (, p<0.01;
, p<0.001).
https://doi.org/10.1371/journal.pone.0190925.g002
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another antibody to ESRP1 (S3 Fig). To determine if ESRP1 expression was restricted to a spe-
cific type of spermatogonial cell, we performed a co-labelling experiment with PLZF and c-
KIT antibodies, which mark type As-Aal and type A1-B spermatogonia respectively [36, 37].
The results showed that ESRP1 is expressed in both Type A and Type B (Fig 3D–3I) spermato-
gonia. To confirm that ESRP1 was not associated with somatic cells, we performed co-localiza-
tion studies with Sox9, a marker for testicular somatic Sertoli cells. Consistent with the ddPCR
data indicating little or no expression of Esrp1 in somatic cells (Fig 1), ESRP1 showed little to
no co-localization with Sox9 in the somatic Sertoli cells (Fig 4).
Fig 3. ESRP1 is expressed in type A and type B spermatogonia. Double labelling immunofluorescence showed that ESRP1 (antibody
HPA023719) is detected in both Type A (PLZF+) and Type B (c-Kit+) spermatogonia, Representative sections of seminiferous tubules were
labelled with antibodies to ESRP1 (A, D, G), PLZF (F), c-Kit (I) and Hoechst nuclear stain (B, E, H). ESRP1 staining in spermatogonia is
present as speckled nuclear reactivity (A, D, G). Arrows indicate double-labelled cells in each image series (D-F; G-I). Very little non-specific
labelling was detected when sections were incubated with non-immune serum (NIS; C). Scale bars: 34.5 μm (A-B); 20.5 μm (C); 10.5 μm
(D-F); 18 μm (G-I).
https://doi.org/10.1371/journal.pone.0190925.g003
Expression of Esrp1 in germ cells
PLOS ONE | https://doi.org/10.1371/journal.pone.0190925 January 11, 2018 8 / 15
The nuclear speckled pattern of reactivity seen in the spermatogonia suggested that ESRP1
may be localized to the spliceosome. To investigate this further, we examined whether ESRP1
co-localized with SC35, a well-known constituent of nuclear speckles and pre-mRNA splicing
[38, 39]. Surprisingly, ESRP1 did not co-localize to SC35+ nuclear speckles (Fig 5).
ESRP1 regulates splicing in a fetal germ cell line (TCam-2 cells)
To investigate if ESRP1 can modulate splicing of target genes in fetal germ cells we examined
the effects of siRNA knockdown of ESRP1 in vitro, using the seminoma-derived TCam-2 cell
line, which has been shown to have characteristics of fetal germ cells (Young et al., 2011). To
first determine the lability of the ESRP1 protein in Tcam2 cells we conducted a cycloheximde
chase analysis and found that ESRP1 protein remains stable in these cells for at least 24 hours.
By 48 hours, small amounts of the protein are still detected by western blot, but by 72 hours no
protein was detected (S4 Fig). We therefore conducted our analyses of siRNA knockdown cells
72 hours post-transfection. Transfection of these cells with two independent siRNA constructs
resulted in efficient knock-down of ESRP1 mRNA and protein, as determined by RT-ddPCR
(Fig 6A), and by western blot (Fig 6B). As previous studies [40] demonstrated that exons 2
and 3 of CTNND1 and exon 23 of DOCK7 are direct targets of ESRP1-mediated splicing, we
designed primers to detect the alternatively spliced and constant exons of these transcripts and
examined their expression by RT-ddPCR in cells treated with or without siRNA. Consistent
with previous reports that ESRP1 mediates exclusion of exons2 and 3 in CTNND1 transcripts,
we detected a shift from the variants lacking exons 2–3 to variants that include these exons in
cells treated with ESRP1 siRNA (Fig 6C). Similarly, greater inclusion of exon 23 in DOCK7
Fig 4. ESRP1 is not localized to somatic (Sertoli) cells. Double labelling immunofluorescence experiments with an
antibody to Sox9 (A) showed that ESRP1 (B; antibody HPA023719) exhibits minimal labelling of somatic Sertoli cells
in the testis. Scale bar: 20 μm all images.
https://doi.org/10.1371/journal.pone.0190925.g004
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transcripts was detected, whereas the expression of the constant exons for both genes remained
unchanged (Fig 6C).
Discussion
In this study we documented the expression of Esrp1 during gonadal development and in dif-
ferentiating cells of the adult gonads. We observed that in mouse fetal gonads, Esrp1mRNA
was specifically detected in germ cells of either sex and absent from somatic gonadal cells.
Esrp1mRNA was also present in a gonocyte-enriched cell fraction and in all germ cells exam-
ined in the postnatal testis; however, it was found at much higher levels in spermatogonia than
in pachytene spermatocytes or round spermatids. Consistent with mRNA levels, ESRP1 pro-
tein expression was detected in cells at the periphery of seminiferous tubules, co-staining with
PLZF and c-Kit, indicating that ESRP1 is present in type A and B spermatogonia but not in
Sox9+ Sertoli cells. Protein expression was also detected in spermatocytes and round sperma-
tids, suggesting that the level of mRNA expression in these cells can sustain detectable protein
production. This raises the possibility that ESRP1 plays a continuing role in splicing of pre-
meiotic transcripts in these more differentiated cells. Spermatogenesis is characterized by a
variety of post-transcriptional regulatory events and alternative splicing may plausibly regulate
these later events [41].
While it is unclear precisely where splicing occurs within the nucleus, it is becoming clear
that constitutive splicing occurs most commonly as co-transcriptional splicing of the pre-
Fig 5. Nuclear ESRP1does not co-localize with the spliceosome marker, SC35. Double labelling
immunofluorescence experiments of ESRP1 (antibody HPA023719) with an antibody to SC35, a marker for the
spliceosome (A), showed that the nuclear ESRP1+ speckles (B) do not overlap with SC35+ nuclear speckles (D). Scale
bar: 20 μm all images.
https://doi.org/10.1371/journal.pone.0190925.g005
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mRNA and that alternate splicing occurs more commonly as a post-transcriptional process
[42]. Spliceosome assembly involves the sequential recruitment of U1, U2, U4, U5 and U6
snRNAs and various small ribonucleoproteins into a macromolecular complex at the pre-
mRNA splice sites, [42]. Studies with the U2-associated protein, SF3b155, have shown that
80% of pre-mRNA splicing, marked by anti-phospho- SF3b155 antibodies, occurs co-tran-
scriptionally, whereas only 10–20% of splicing occurs post-transcriptionally in nuclear speck-
les, which are positive for SC35 [43]. Consistent with previous findings indicating that ESRP1
is a splicing factor, ESRP1 was localized to numerous small nuclear speckles in spermatogonia.
However, the lack of ESRP1 co-localization with SC35 suggests that ESRP1 is more likely to be
involved in constitutive, co-transcriptional rather than post-transcriptional, alternate splicing
events in SC35+ speckles during spermatogonial self-renewal and differentiation. Despite the
Fig 6. ESRP1-mediated alternative splicing in TCam-2 cells. A. TCam-2 cells transfected with siRNA constructs for
ESRP1 displayed a dramatic (~85%) and significant (n = 3 each group; p<0.0001, Student’s t-test) decrease in
expression of ESRP1 mRNA. Similar data were obtained in two independent experiments. B. By western blot analysis,
a distinct 75kD band for ESRP1 was detected in non-transfected and control siRNA-transfected TCam2 cells but was
not detectable in cells transfected with either siRNA construct. Similar data were obtained in two independent
experiments. C. RT-PCR using primers specific to splice variants of CTNND1 and DOCK7 showed that loss of ESRP1
expression promoted inclusion of exons 2–3 in CTNND1 transcripts and inclusion of exon 23 in DOCK7 transcripts.
By contrast no changes were detected for the constant exons in these genes. The splicing pattern and band size are
illustrated for each transcript variant.
https://doi.org/10.1371/journal.pone.0190925.g006
Expression of Esrp1 in germ cells
PLOS ONE | https://doi.org/10.1371/journal.pone.0190925 January 11, 2018 11 / 15
lack of co-localization with SC35, siRNA experiments indicated that down-regulation of
ESRP1 expression resulted in expected changes in the splicing of two known ESRP1 target pre-
mRNAs (CTNND1 and DOCK7). These data suggest that ESRP1 plays a role in regulating
alternative splicing in male germ cells in vitro. Whether this extends to regulating these ESRP1
target genes in the testis in vivo remains to be determined. The standard spliced form of CD44
mRNA is expressed in the testis but not the splice variant, CD44v6, mediated by ESRP1 [44].
Similarly, while FGFR2 is expressed in spermatogonia, spermatocytes and spermatids [45], it is
not known if this is the IIIC or the IIIB isoform.
Transcriptomic analysis of mouse spermatogenesis has identified over 13,000 alternative
splicing events [8], indicating that alternative splicing is a key driver of cell differentiation
events during spermatogenesis. However, while ESRP1 is known as a an important regulator
of alternative splicing in epithelial tissues, in the testis it appears not to function in nuclear
speckles associated with post-transciptional alternate splicing. Our data cannot exclude an
alternate splicing role for ESRP1 in the testis and combined expression and bioinformatic
analyses may yet yield information about potential ESRP1 target genes in the testis. Addition-
ally, analyses of spermatogenesis and spermiogenesis in Esrp1-/- mice will be required to deter-
mine the precise role of Esrp1 in spermatogonia.
Supporting information
S1 Fig. Analysis of separated germ cell populations. Droplet digital RT-PCR analyses of BSA
gradient-separated cells from mouse testes confirmed that the isolated populations of cells are
enriched for spermatogonia (S; Ngn3 and Ccnd1 expressing) and pachytene spermatids (P;
Dnah8 expressing). Gonocytes (G), like spermatogonia (S), express Plzf but express very low
levels of Ccnd1. In another study we have shown that round spermatids express elevated Tob1
[29]. Statistical analyses: One-way ANOVA with Tukey’s post-hoc analyses; n = 3 in all cases,
except RS (n = 2); , p<0.05; , p<0.0001.
(TIF)
S2 Fig. siRNA knockdown of Esrp1 demonstrates antibody specificity. Immunofluores-
cence of TCam-2 cells transfected with negative control-siRNA (A-D) or with ESRP1-siRNA
(E-H). In control cells, ESRP1 (A) showed a granular nuclear immunofluorescent staining
(HPA023719; Sigma; 1:100), which was greatly depleted in siRNA-treated cells (E). Cells were
counterstained with phalloidin to stain filamentous cortical actin (B, F) and Hoechst dye to
label cell nuclei (C, G). Merged images are shown in D and F. Scale bar, 20 μm for all images.
(TIF)
S3 Fig. Immunostaining with a second ESRP1 antibody shows a similar expression pattern.
ESRP1 immunofluorescence in adult mouse testis using another antibody (Sigma-Aldrich,
HPA023720; Lot: 3070388) showed similar nuclear staining in spermatogonia (A, C, arrows)
to that observed with HPA023719 (Fig 3). Non-immune IgG (D, F) showed no reactivity in
the seminiferous tubules but did show but nonspecific labelling in the interstitial Leydig cells
(). Section were counter-stained with Hoechst dye to label nuclei (B, E) and merged images
are shown in (C, F). Scale bar: A-C, 30 μm; D-F, 20 μm.
(TIF)
S4 Fig. ESRP1 protein is depleted 72 hours after blocking translation. Immunoblot of cyclo-
heximide (CHX) chase experiment in TCam-2 cells showing stability of ESRP1 protein after
arrest of protein synthesis. ESRP1 protein (75kD) was still detected weakly after 48 hours but
was absent by 72 hours. Beta-actin (43 kD) was used as a loading control and was present in all
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samples. ESRP1 antibody HPA023719)
(TIF)
S1 File. Supplementary legends.
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